Table 2 Membrane complications

Masculine

46 (63%)

38 (80,8%)

24 (75%)

0.094

Number of membrane changes

24 (32.8%)

15 (31.9%)

22(63.1%)

0.022*

Mechanical ventilation days

16.1 (11.3–22.6)

17.2 (10.6–27)

17.8 (10.5–28.7)

0.37

ICU stay

22 (8.8–44)

25.6 (14.2–45)

22.9 (15.3–38.5)

0.4

Hospital stay

25 ((14–58)

30.5 (18–52.5)

27 (16–46)

0.378

Mortality

22 (30.1%)

20 (42.5%)

16 (50%)

0.118

0.001*

 Low transference

12(50%)

7(14.8%)

18(56.2%)

 Hemolysis

2 (4.2%)

 Infection

3(4.1%)

1(2.1%)

 Thrombosis

2(2.7%)

Complications n (%)

 Mayor bleed

8(10.9%)

6 (12.7%)

6 (18.7%)

0.551

 Renal replacement therapy

25 (34.2%)

15 (31.9%)

22 (68.7%)

0.001*

 Bomb failure

2(2.7%)

1(2.1)

0.647

 Oxigenator failure

9(12.3%)

7 (14.8%)

6(18.7%)

0.687

 Delirium

39 (53,4%)

28 (59,5%)

16 (50%)

0.676

Support mode, n(%)

0.063

 Venovenous ECMO

50 (68,4%)

42 (89,3%)

23 (71,8%)

 Venoarterial Venoarterial

22 (30,1%)

3 (6,38%)

8 (25%)

 Venoarterial venous ECMO

1 (1,3%)

2 (4,2%)

1(3,1%)

Type of infection, n (%)

 SARS-CoV-2

51 (69.8%)

41(87.2%)

25 (78.1%)

0.086